Carlucci S, Beschin A, Tuosto L, Ameglio F, Gandolfo G M, Cocito C, Fiorucci F, Saltini C, Piccolella E
Department of Cellular and Developmental Biology, La Sapienza, University of Rome.
Infect Immun. 1993 Feb;61(2):439-47. doi: 10.1128/iai.61.2.439-447.1993.
The Mycobacterium bovis antigen complex A60 is known to be immunodominant in tuberculosis and to have a protective effect against experimental infection in vitro and in vivo. To identify immunodominant and possibly protective antigens in pulmonary tuberculosis, the T-cell repertoire directed to nitrocellulose-bound fractions of A60 antigen was analyzed in active tuberculosis patients during the course of the infection and after recovery. The results show that patients infected with Mycobacterium tuberculosis acquired complete A60-T-cell reactivity only in the late phases of infection. At disease onset, patients with active tuberculosis were characterized by (i) T-cell unresponsiveness to most A60 fractions, (ii) high tumor necrosis factor alpha production, and (iii) low gamma interferon (IFN-gamma) release. Several weeks after chemotherapy, the unresponsive state disappeared and the following reverse situation was observed: (i) high blastogenic response to almost all A60 fractions, (ii) low tumor necrosis factor alpha release, and (iii) high IFN-gamma production. In addition, 60% of these patients significantly responded against seven A60 fractions (61 to 58, 56 to 53, 49 to 46, 46 to 44, 35 to 33, 33 to 30, and 30 to 28 kDa), indicating that they included immunodominant antigens. Furthermore, only the fractions within the molecular mass ranges of 56 to 44 and 35 to 28 kDa induced IFN-gamma synthesis. One year after complete recovery from infection, more than 60% of past-active tuberculosis subjects had memory T cells specific for the immunodominant fractions of 61 to 58, 56 to 53, 49 to 46, and 33 to 30 kDa. Since the same fractions induced the strongest IFN-gamma production, known to exhibit antimycobacterial effects, it is suggested that these may represent the inducers of a protective immune response.
已知牛分枝杆菌抗原复合物A60在结核病中具有免疫优势,并且在体外和体内对实验性感染具有保护作用。为了鉴定肺结核中的免疫优势抗原以及可能具有保护作用的抗原,我们分析了活动性肺结核患者在感染过程中和康复后针对与硝酸纤维素结合的A60抗原组分的T细胞库。结果显示,感染结核分枝杆菌的患者仅在感染后期才获得完全的A60-T细胞反应性。在疾病发作时,活动性肺结核患者的特征为:(i)对大多数A60组分的T细胞无反应性;(ii)高肿瘤坏死因子α产生;(iii)低γ干扰素(IFN-γ)释放。化疗数周后,无反应状态消失,观察到以下相反情况:(i)对几乎所有A60组分的高增殖反应;(ii)低肿瘤坏死因子α释放;(iii)高IFN-γ产生。此外,这些患者中有60%对七个A60组分(61至58、56至53、49至46、46至44、35至33、33至30和30至28 kDa)有明显反应,表明它们包含免疫优势抗原。此外,只有分子量范围在56至44和35至28 kDa之间的组分诱导IFN-γ合成。从感染中完全康复一年后,超过60%的既往活动性肺结核患者具有针对61至58、56至53、49至46和33至30 kDa免疫优势组分的记忆T细胞。由于相同的组分诱导最强的IFN-γ产生,已知其具有抗分枝杆菌作用,因此提示这些组分可能代表保护性免疫反应的诱导剂。